TickerFacts.

Cannabis Bioscience International Holdings, Inc. (CBIH): Revenue

Annual figures by period end, from SEC filings.

$303.0K
Year ended 2025-05-31
$123.6K
Trailing 12 months to 2026-02-28
$316.8K2023-05-31: $316.8K2024-05-31: $248.8K2025-05-31: $303.0K$303.0K
2023-05-31 Revenue (USD) 2025-05-31
Period endedRevenueChange YoYSource filing
2025-05-31$303.0K+21.8%2025-09-22, From 2024-06-01
2024-05-31$248.8K-21.5%2025-09-22, From 2023-06-01
2023-05-31$316.8Kn/a2024-09-16, From 2022-06-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$303.0K+21.8%
OneMedNet Corp (ONMD)2025-12-31$1.36M+111.4%
iSpecimen Inc. (ISPC)2025-12-31$1.93M-79.2%
Absci Corp (ABSI)2025-12-31$2.80M-38.2%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$6.16M-34.2%
Foxo Technologies Inc. (FOXO)2025-12-31$16.37M+304.0%
OmniAb, Inc. (OABI)2025-12-31$18.67M-29.3%
MaxCyte, Inc. (MXCT)2025-12-31$33.03M-14.5%
NRC Health (NRC)2025-12-31$137.39M-4.0%

Compare CBIH, ONMD, ISPC, ABSI side by side · Screen every company in Services-Commercial Physical & Biological Research ↗